Study on endometrial cancer patients and their treatment outcome in BPKMCH

Authors

  • Manju Pandey Gyneoncology Unit, Depart - ment of Surgical Oncology, B.P. Koirala Memorial Cancer Hospital, Bharatpur, Chitwan, Nepal https://orcid.org/0000-0001-6962-2420
  • Bijaya Chandra Acharya Gyneoncology Unit, Depart - ment of Surgical Oncology, B.P. Koirala Memorial Cancer Hospital, Bharatpur, Chitwan, Nepal
  • Hemnath Subedi Gyneoncology Unit, Depart - ment of Surgical Oncology, B.P. Koirala Memorial Cancer Hospital, Bharatpur, Chitwan, Nepal
  • Sarita Rana Gurung Gyneoncology Unit, Depart - ment of Surgical Oncology, B.P. Koirala Memorial Cancer Hospital, Bharatpur, Chitwan, Nepal
  • Jitendra Pariyar Gynecology Department, Civil Service Hospital, Kathmandu, Nepal
  • Shivajee Paudel Department of Radiation Oncology, B.P. Koirala Memorial Cancer Hospital, Bharatpur, Chitwan, Nepal
  • Greta Pandey Department of Pathology, B.P. Koirala Memorial Cancer Hospital, Bharatpur, Chitwan, Nepal
  • Nitu Paudel Department of Radiology, B.P. Koirala Memorial Cancer Hospital, Bharatpur, Chitwan, Nepal
  • Hari Prasad Upadhyay Department of Statistics, Birendra Multiple Campus, Bharatpur-10, Chitwan, Nepal
  • Binuma Shrestha Gyneoncology Unit, Depart - ment of Surgical Oncology, B.P. Koirala Memorial Cancer Hospital, Bharatpur, Chitwan, Nepal
  • Damodar Tiwari Department of Pediatrics, Bharatpur Hospital, Chitwan, Nepal https://orcid.org/0000-0001-6962-2420

Keywords:

adjuvant chemotherapy, clinicopathologic characteristics, postmenopausal, obesity, endometrial carcinoma

Abstract

Background: There are  few studies on endometrial carcinoma in Nepal so present study aims to evaluate the clinicopathologic characteristics of endometrial cancer patients along with their treatment outcome.

Material and Methods: This is a descriptive study conducted from January 2011 to December 2020 and all patients of endometrial carcinoma who had undergone primary surgery at B.P. Koirala Memorial Cancer Hospital were included. Socio-demographic characteristics, clinical presentations, histologic type, treatment modalities and outcomes were obtained and analyzed.

Results: The mean age was found to be 58 8.32 years. Most were postmenopausal accounting for 86%. Medical co-morbidities were associated in 40% of patients. Most common presentation was postmenopausal bleeding seen in 68% of patients. Total abdominal hysterectomy and bilateral salpingo-oophorectomy was done in 48% of patients. The main histologic type was endometrioid carcinoma observed in 96% of patients. Low grade carcinoma was found in 78% of patients out of which grade 1 accounting for 50% and rest grade 2 while high grade carcinoma was found 22% of patients. 64% of patients required adjuvant therapy. Recurrence was seen in 16% of patients.

Conclusions: Endometrial carcinoma is common in post menopausal age group. Endometrioid variety is the commonest histologic type. Clinicopathologic characters of endometrial carcinoma affect the prognosis of the patient.

DOI: https://doi.org/10.46405/ejms.v3i2.382

Downloads

Download data is not yet available.
Abstract
30
Download Full Text PDF
26

Downloads

Published

2021-12-30

How to Cite

Pandey , M., Acharya , B. C., Subedi , H., Gurung , S. R., Pariyar , J., Paudel , S., … Tiwari , D. (2021). Study on endometrial cancer patients and their treatment outcome in BPKMCH. Europasian Journal of Medical Sciences, 5(2). Retrieved from https://nepjol.info/index.php/ejms/article/view/77259

Issue

Vol. 5 No. 2 (2021): Europasian Journal of Medical Sciences (EJMS) | 2021 (July - December) Issue 6

Section

Original Articles

License

Copyright (c) 2021 Manju Pandey , Bijaya Chandra Acharya , Hemnath Subedi , Sarita Rana Gurung , Jitendra Pariyar , Shivajee Paudel , Greta Pandey , Nitu Paudel , Hari Prasad Upadhyay , Binuma Shrestha, Damodar Tiwari

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

The author(s) retain the ownership of the copyrights for their work published in EJMS without any restrictions. Upon submission, the author(s) grants EJMS a license to publish, including to display, store, copy, and reuse the published content.

License to Publish
By submitting a manuscript to EJMS, the author(s) grant the journal a non-exclusive license to:

  • Publish and distribute the content in all formats, media, and platforms (both existing and future), while identifying EJMS as the original publisher.
  • Reproduce, display, and store the content in both print and online formats, including institutional and digital repositories.
  • Translate, adapt, and summarize the work, including reprints, extracts, and abstracts.
  • Develop derivative works based on the original content.
  • Include the work in electronic databases and provide links to third-party materials.

Creative Commons Licensing
In addition to EJMS’s publishing rights, authors grant third parties the right to use, share, and distribute their work under the Creative Commons Attribution 4.0 (CC BY 4.0) International License. This allows unrestricted use of the content, provided proper attribution is given to the original author(s) and the journal.